Page last updated: 2024-08-23

phenyl acetate and Acute Coronary Syndrome

phenyl acetate has been researched along with Acute Coronary Syndrome in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	12 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kastelein, JJP; Lincoff, AM; Mani, P; Menon, V; Nicholls, SJ; Nissen, SE; Puri, R; Schwartz, GG; Shao, M	1
Bash, D; Brennan, DM; Cavender, MA; Jukema, JW; Kastelein, JJ; Koenig, W; Lincoff, AM; Menon, V; Nambi, V; Nicholls, SJ; Nissen, SE; Rosenson, RS; Schwartz, GG; Wright, RS	1
O'Donoghue, ML	1
Corsini, A; Ferri, N	1
Elliott, M; Goulder, M; Hislop, C; Rosenson, RS; Stasiv, Y; Waters, D	1
Cantor, WJ; Džavík, V; Horlick, EM; Ing, D; Lan, J; Lavi, S; Miner, SE; Osten, MD; Overgaard, CB; Plante, S; Robbins, K; Thorpe, K; Yip, PM	1
Rosenson, RS	1
Armstrong, PW; Bolognese, L; Braunwald, E; Califf, RM; Durand, E; Giugliano, RP; Harrington, RA; Hasselblad, V; Kong, DF; Moliterno, DJ; Newby, LK; Prabhakaran, D; Rasoul, S; Stone, GW; Théroux, P; Tricoci, P; Van de Werf, F; White, HD	1
Hack, CE; Krijnen, PA; Niessen, HW	1
Fraser, H; Goulder, MA; Hislop, C; Rosenson, RS	1
Bash, D; Cavender, MA; Hislop, C; Kastelein, JJ; Nicholls, SJ; Rosenson, RS; Schwartz, G; Waters, DD	1

Reviews

3 review(s) available for phenyl acetate and Acute Coronary Syndrome

Article	Year
[Role of secreted and lipoprotein-associated phospholipase A2 in cardiovascular risk]. Giornale italiano di cardiologia (2006), 2014, Volume: 15, Issue:12 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetates; Acute Coronary Syndrome; Atherosclerosis; Benzaldehydes; Clinical Trials, Phase III as Topic; Coronary Artery Disease; Humans; Indoles; Keto Acids; Lipoproteins; Oximes; Phospholipase A2 Inhibitors; Phospholipases A	2014
Varespladib. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2011, Volume: 11, Issue:2 Topics: Acetates; Acute Coronary Syndrome; Animals; Clinical Trials as Topic; Humans; Indoles; Keto Acids	2011
Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials. Circulation. Cardiovascular quality and outcomes, 2011, Volume: 4, Issue:4 Topics: Acetates; Acute Coronary Syndrome; Administration, Cutaneous; Angioplasty; Electrocardiography; Eptifibatide; Hemorrhage; Humans; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Randomized Controlled Trials as Topic; Risk; Survival Analysis; Tirofiban; Tyrosine	2011

Trials

7 trial(s) available for phenyl acetate and Acute Coronary Syndrome

Article	Year
Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial. JAMA cardiology, 2019, 04-01, Volume: 4, Issue:4 Topics: Acetates; Acute Coronary Syndrome; Aged; Angina, Unstable; Australia; C-Reactive Protein; Death; Europe; Female; Humans; India; Indoles; Keto Acids; Male; Middle Aged; Myocardial Infarction; New Zealand; North America; Phospholipase A2 Inhibitors; Placebos; Risk Factors; Stroke; Treatment Outcome	2019
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. JAMA, 2014, Jan-15, Volume: 311, Issue:3 Topics: Acetates; Acute Coronary Syndrome; Aged; Angina, Unstable; Atherosclerosis; Atorvastatin; Double-Blind Method; Early Termination of Clinical Trials; Female; Heptanoic Acids; Humans; Indoles; Keto Acids; Male; Middle Aged; Myocardial Infarction; Phospholipases A; Phospholipases A2, Secretory; Pyrroles; Risk; Stroke; Survival Analysis; Treatment Outcome	2014
Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients. Journal of the American College of Cardiology, 2010, Sep-28, Volume: 56, Issue:14 Topics: Acetates; Acute Coronary Syndrome; Aged; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Heptanoic Acids; Humans; Indoles; Keto Acids; Logistic Models; Male; Middle Aged; Phospholipases A2, Secretory; Prospective Studies; Pyrroles; Reference Values; Treatment Outcome	2010
The sPLA2 Inhibition to Decrease Enzyme Release after Percutaneous Coronary Intervention (SPIDER-PCI) trial. Circulation, 2010, Dec-07, Volume: 122, Issue:23 Topics: Acetates; Acute Coronary Syndrome; Aged; Angioplasty; Biomarkers; Enzyme Inhibitors; Female; Humans; Indoles; Keto Acids; Male; Middle Aged; Phospholipases A2, Secretory	2010
After FRANCIS: next steps in the clinical evaluation of varespladib methyl. Future cardiology, 2011, Volume: 7, Issue:1 Topics: Acetates; Acute Coronary Syndrome; Analysis of Variance; Anticholesteremic Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hyperlipidemias; Indoles; Keto Acids; Logistic Models; Male; Middle Aged; Phospholipases A2, Secretory; Pyrroles	2011
Anti-inflammatory effects of varespladib methyl in diabetic patients with acute coronary syndrome. Cardiovascular drugs and therapy, 2011, Volume: 25, Issue:6 Topics: Acetates; Acute Coronary Syndrome; Anti-Inflammatory Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Group II Phospholipases A2; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Interleukin-6; Keto Acids; Male; Middle Aged; Pyrroles; Treatment Outcome	2011
Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial. Cardiovascular drugs and therapy, 2012, Volume: 26, Issue:1 Topics: Acetates; Acute Coronary Syndrome; Atorvastatin; Double-Blind Method; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Inflammation; Keto Acids; Phospholipases A2, Secretory; Pyrroles	2012

Other Studies

2 other study(ies) available for phenyl acetate and Acute Coronary Syndrome

Article	Year
Acute coronary syndromes: targeting inflammation-what has the VISTA-16 trial taught us? Nature reviews. Cardiology, 2014, Volume: 11, Issue:3 Topics: Acetates; Acute Coronary Syndrome; Female; Humans; Indoles; Male; Myocardial Infarction; Phospholipases A	2014
Letter by Krijnen et al regarding article, "The sPLA2 Inhibition to Decrease Enzyme Release after Percutaneous Coronary Intervention (SPIDER-PCI) trial". Circulation, 2011, Sep-13, Volume: 124, Issue:11 Topics: Acetates; Acute Coronary Syndrome; Angioplasty; Female; Humans; Indoles; Male; Phospholipases A2, Secretory	2011